EFFECT OF PERGOLIDE MESYLATE, AN ERGOLINE, IN ANIMAL-MODELS OF PARKINSONS-DISEASE - IMPLICATIONS FOR THERAPY

被引:0
|
作者
KLAWANS, HL
KOLLER, WC
DIAMOND, BI
NAUSIEDA, PA
WEINER, WJ
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:157 / 157
页数:1
相关论文
共 50 条
  • [41] LONG-TERM EFFICACY OF PERGOLIDE IN PATIENTS WITH PARKINSONS-DISEASE
    SAGE, JI
    DUVOISIN, RC
    CLINICAL NEUROPHARMACOLOGY, 1986, 9 (02) : 160 - 164
  • [42] LONG-TERM EFFICACY OF PERGOLIDE IN PATIENTS WITH PARKINSONS-DISEASE
    SAGE, JI
    DUVOISIN, RC
    ANNALS OF NEUROLOGY, 1985, 18 (01) : 137 - 137
  • [43] TREATMENT OF PARKINSONS-DISEASE WITH PERGOLIDE - A DOUBLE-BLIND-STUDY
    AHLSKOG, JE
    MUENTER, MD
    MAYO CLINIC PROCEEDINGS, 1988, 63 (10) : 969 - 978
  • [44] EFFECT OF DOPAMINE AGONIST (LERGOTRILE MESYLATE) THERAPY ON 24 HOUR SECRETION OF PROLACTIN IN TREATED PARKINSONS-DISEASE
    BELL, RD
    CARRUTH, A
    ROSENBERG, RN
    BOYAR, RM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 47 (04): : 807 - 811
  • [45] PERGOLIDE MESYLATE - NEW THERAPY FOR PARKINSON DISEASE
    TANNER, CM
    KLAWANS, HL
    ANNALS OF INTERNAL MEDICINE, 1982, 96 (04) : 522 - 523
  • [46] LOSS OF STRIATAL HISTAMINE H-2 RECEPTORS IN HUNTINGTONS-CHOREA BUT NOT IN PARKINSONS-DISEASE - COMPARISION WITH ANIMAL-MODELS
    MARTINEZMIR, MI
    POLLARD, H
    MOREAU, J
    TRAIFFORT, E
    RUAT, M
    SCHWARTZ, JC
    PALACIOS, JM
    SYNAPSE, 1993, 15 (03) : 209 - 220
  • [47] PATHOGENESIS AND ANIMAL STUDIES OF PARKINSONS-DISEASE
    OERTEL, WH
    KUPSCH, A
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1993, 6 (03): : 323 - 332
  • [48] MILACEMIDE THERAPY FOR PARKINSONS-DISEASE
    GIUFFRA, ME
    SETHY, VH
    DAVIS, TL
    MOURADIAN, MM
    CHASE, TN
    MOVEMENT DISORDERS, 1993, 8 (01) : 47 - 50
  • [49] COMPLICATIONS OF THERAPY IN PARKINSONS-DISEASE
    KOFMAN, OS
    CANADIAN FAMILY PHYSICIAN, 1983, 29 (JAN) : 87 - 91
  • [50] NONDRUG THERAPY OF PARKINSONS-DISEASE
    CAIRD, FI
    SCOTTISH MEDICAL JOURNAL, 1986, 31 (02) : 129 - 132